Skip to content
FY'25FY'24FY'23FY'22
$33.59M+19.7%$28.05M+24.6%$22.52M+31.4%$17.13M-26.3%
$13.6M-6.8%$14.6M+13.9%$12.82M-0.4%$12.87M+31.6%
$12.08M-8.9%$13.27M-0.4%$13.32M-11.2%$14.99M+26.9%
$22.75M+3.7%$21.95M-12.0%$24.94M-7.0%$26.82M+49.9%
-$47.39M+5.1%-$49.92M+11.7%-$56.56M+10.5%-$63.22M-33.8%
-141.1%+36.9pp-178%+73.2pp-251.2%+118pp-369%-166pp
$1.43M-22.5%$1.84M-56.2%$4.21M
$3.05M-26.0%$4.13M+125%$1.84M+107%
$40K$31K+105%-$583K-741%
-$47.12M-0.5%-$46.89M+10.6%-$52.47M+13.7%-$60.81M+17.3%
-140.3%+26.9pp-167.2%+65.8pp-233%+122pp-354.9%-38.4pp
-$1.06+1.9%-$1.08+11.5%-$1.22+14.1%-$1.42
-$44.14M+5.2%-$46.56M+12.9%-$53.46M+11.5%-$60.38M-32.0%
-131.4%+34.6pp-166%+71.4pp-237.4%+115pp-352.4%-156pp
-$47.39M+5.1%-$49.92M+11.7%-$56.56M+10.5%-$63.22M-33.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Rapid Micro Biosystems's revenue?
Rapid Micro Biosystems (RPID) generated $34.4M in revenue over the trailing twelve months, up 16.0% year over year.
Is Rapid Micro Biosystems profitable?
Rapid Micro Biosystems is not currently profitable: it reported a net loss of $50.1M over the trailing twelve months, a -145.8% net margin.
What is Rapid Micro Biosystems's earnings per share?
Rapid Micro Biosystems's diluted EPS over the trailing twelve months is $-1.11.
Where does Rapid Micro Biosystems's income statement data come from?
Every line is extracted from Rapid Micro Biosystems's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.